Streptococcus agalactiae GAPDH is a virulence-associated immunomodulatory protein.
Certain extracellular proteins produced by several pathogenic microorganisms interfere with the host immune system facilitating microbial colonization and were thus designated virulence-associated immunomodulatory proteins. In this study, a protein with B lymphocyte stimulatory activity was isolated from culture supernatants of Streptococcus agalactiae strain NEM316. This protein, with an apparent molecular mass of 45 kDa, was identified as GAPDH by N-terminal amino acid sequencing. The gapC gene was cloned and expressed in Escherichia coli for the production of a recombinant histidyl-tagged protein. The recombinant GAPDH (rGAPDH), purified in an enzymatically active form, induced in vitro an up-regulation of CD69 expression on B cells from normal and BCR transgenic mice. In addition, rGAPDH induced an increase in the numbers of total, but not of rGAPDH-specific, splenic Ig-secreting cells in C57BL/6 mice treated i.p. with this protein. These in vitro- and in vivo-elicited B cell responses suggest that the B cell stimulatory effect of rGAPDH is independent of BCR specificity. A S. agalactiae strain overexpressing GAPDH showed increased virulence as compared with the wild-type strain in C57BL/6 mice. This virulence was markedly reduced in IL-10-deficient and anti-rGAPDH antiserum-treated mice. These results suggest that IL-10 production, which was detected at higher concentrations in the serum of rGAPDH-treated mice, is important in determining the successfulness of the host colonization by S. agalactiae and they highlight the direct role of GAPDH in this process. Taken together, our data demonstrate that S. agalactiae GAPDH is a virulence-associated immunomodulatory protein.
Madureira
Pedro
P
ICBAS-Instituto de Ciências Biomédicas de Abel Salazar, Porto, Portugal.
Baptista
Marina
M
Vieira
Marta
M
Magalhães
Vanessa
V
Camelo
Ana
A
Oliveira
Liliana
L
Ribeiro
Adília
A
Tavares
Delfina
D
Trieu-Cuot
Patrick
P
Vilanova
Manuel
M
Ferreira
Paula
P
D000818:Animals; D000942:Antigens, Bacterial / Q000235:genetics; D001402:B-Lymphocytes; D001426:Bacterial Proteins / Q000235:genetics / Q000502:physiology*; D024581:Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) / Q000502:physiology*; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000502:physiology*; D007155:Immunologic Factors; D016753:Interleukin-10 / Q000032:analysis / Q000096:biosynthesis*; D008213:Lymphocyte Activation; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D013292:Streptococcus agalactiae / Q000201:enzymology* / Q000276:immunology / Q000472:pathogenicity*; D014774:Virulence; D037521:Virulence Factors
D000942:Antigens, Bacterial; D001426:Bacterial Proteins; C469817:GapC protein, Streptococcus; D007155:Immunologic Factors; D037521:Virulence Factors; D016753:Interleukin-10; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases; C518150:GAPDH protein, Streptococcus agalactiae; D024581:Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)